from MarketScreener

“Sichuan Kelun-Biotech Biopharmaceutical (HKG:6990) priced its Hong Kong initial public offering on Monday to raise HK$1.26 billion in net proceeds from the offering.

The biopharmaceutical company sold 22,446,100 shares at HK$60.60 per share, the bottom of the offering’s price range of as high as HK$72.80 apiece…”

Continue reading at the original source, linked here.